Lee P. Lim

Active 1998–2022

32
Papers
28,946
Citations
29
h-index
32
i10-index

Citations

Citations per year for Lee P. Lim1970: 1 citations1986: 1 citations1993: 2 citations1995: 1 citations1996: 1 citations1998: 2 citations1999: 3 citations2000: 3 citations2001: 16 citations2002: 95 citations2003: 189 citations2004: 288 citations2005: 386 citations2006: 462 citations2007: 607 citations2008: 721 citations2009: 831 citations2010: 845 citations2011: 700 citations2012: 658 citations2013: 542 citations2014: 476 citations2015: 366 citations2016: 252 citations2017: 228 citations2018: 236 citations2019: 583 citations2020: 588 citations2021: 509 citations2022: 452 citations2023: 364 citations2024: 570 citations2025: 288 citations2026: 9 citations1971–1985: no citations, so these years are not shown1987–1992: no citations, so these years are not shown1994: no citations, so this year is not shown1997: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,175 citing papers, 32.9% of this breakdownChina: 1,869 citing papers, 14.7% of this breakdownGermany: 663 citing papers, 5.2% of this breakdownUnited Kingdom: 625 citing papers, 4.9% of this breakdownItaly: 497 citing papers, 3.9% of this breakdownJapan: 412 citing papers, 3.3% of this breakdownCanada: 345 citing papers, 2.7% of this breakdownFrance: 340 citing papers, 2.7% of this breakdownAustralia: 283 citing papers, 2.2% of this breakdownIndia: 249 citing papers, 2% of this breakdownSpain: 246 citing papers, 1.9% of this breakdownSouth Korea: 222 citing papers, 1.8% of this breakdown
0%32.9%Other 21.8%

Fields

  • Biochemistry, Genetics and Molecular Biology74.1%
  • Medicine13.4%
  • Agricultural and Biological Sciences8.5%
  • Immunology and Microbiology1.7%
  • Neuroscience1%
  • Environmental Science0.3%
  • Other1%

Topics

  • MicroRNA in disease regulation18.4%
  • Cancer-related molecular mechanisms research7.6%
  • Circular RNAs in diseases7.3%
  • RNA Research and Splicing5.4%
  • RNA modifications and cancer4.8%
  • RNA Interference and Gene Delivery4.5%
  • Other52%

Coauthors

All papers

Open in search
  1. Acquired Resistance to KRAS G12C Inhibition in Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , J. David Lawson, Peter Olson, Piro Lito, Sai-Hong I. Ou, James G. Christensen, Pasi A. Jänne, Andrew J. Aguirre - New England Journal of Medicine 2021 cited by 1,164

  2. Diverse alterations associated with resistance to KRAS(G12C) inhibition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2021 cited by 447

  3. MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed Pairing

    Authors: , , , , , - Molecular Cell 2007 cited by 3,800

  4. Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kenneth Ng, Juliana Eng, Isabel R. Preeshagul, W. Victoria Lai, John J. Fiore, Afsheen N. Iqbal, Daniela Molena, Gaetano Rocco, Bernard J. Park, Lee P. Lim, Mark Junjie Li, Candace Tong-Li, Madhawa De Silva, David Chan, Connie I. Diakos, Malinda Itchins, Stephen Clarke, Nick Pavlakis, Adrian V. Lee, Natasha Rekhtman, Jason C. Chang, William D. Travis, Gregory J. Riely, David B. Solit, Mithat Gönen, Valerie W. Rusch, Andreas Rimner, Daniel R. Gomez, Alexander Drilon, Howard I. Scher, Sohrab P. Shah, Michael F. Berger, Maria E. Arcila, Marc Ladanyi, Ross L. Levine, Ronglai Shen, Pedram Razavi, Jorge S. Reis‐Filho, David R. Jones, Charles M. Rudin, James M. Isbell, Bob T. Li - Nature Medicine 2022 cited by 185

  5. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

    Authors: , , , , , , , , - Nature 2005 cited by 4,796

  6. Widespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarity

    Authors: , , , , , , - RNA 2006 cited by 962

  7. An Abundant Class of Tiny RNAs with Probable Regulatory Roles in Caenorhabditis elegans

    Authors: , , , - Science 2001 cited by 3,260

  8. A microRNA component of the p53 tumour suppressor network

    Authors: , , , , , , , , , , , , , , , - Nature 2007 cited by 2,701

  9. Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse

    Authors: , , , , , , , , , , , , - Journal of Thoracic Oncology 2017 cited by 137

  10. Prediction of Plant MicroRNA Targets

    Authors: , , , , , - Cell 2002 cited by 2,310

  11. Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing

    Authors: , , , , , , , , , , , , - RNA 2006 cited by 788

  12. The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution

    Authors: , , , , , , , - Science 2005 cited by 1,502

  13. The microRNAs of Caenorhabditis elegans

    Authors: , , , , , , , - Genes & Development 2003 cited by 1,232

  14. Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2019 cited by 163

  15. Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients

    Authors: , , , , , , , , , , , , - Clinical Cancer Research 2015 cited by 241

  16. A computational analysis of sequence features involved in recognition of short introns

    Authors: , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2001 cited by 374

  17. Vertebrate MicroRNA Genes

    Authors: , , , , - Science 2003 cited by 1,220

  18. Plasma MicroRNAs as Sensitive and Specific Biomarkers of Tissue Injury

    Authors: , , , , , , , , , , - Clinical Chemistry 2009 cited by 618

  19. Simple, quantitative primer-extension PCR assay for direct monitoring of microRNAs and short-interfering RNAs

    Authors: , , , , - RNA 2005 cited by 430

  20. A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew D. Hellmann, Alexander Drilon, Gregory J. Riely, Valerie W. Rusch, David R. Jones, Andreas Rimner, Charles M. Rudin, James M. Isbell, Bob T. Li - JNCI Journal of the National Cancer Institute 2018 cited by 125

  21. Blood-Based Surveillance Monitoring of Circulating Tumor DNA From Patients With SCLC Detects Disease Relapse and Predicts Death in Patients With Limited-Stage Disease

    Authors: , , , , , , , , , , , , , , , , , - JTO Clinical and Research Reports 2020 cited by 23

  22. Circulating Tumor DNA as a Biomarker of Radiographic Tumor Burden in SCLC

    Authors: , , , , , , , , , , , , , , , , , , , , , - JTO Clinical and Research Reports 2020 cited by 16

  23. Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA

    Authors: , , , , , , - Lung Cancer 2019 cited by 81

  24. MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle Progression

    Authors: , , , , , , , , , , , - Molecular and Cellular Biology 2008 cited by 556